Allergan BIOCELL® Textured Breast Implant

Home » Allergan BIOCELL Textured Breast Implant

Details about the Allergan BIOCELL® Textured Breast Implant Recalled

Textured breast implants are selected by women because their rough surfaces allow for an interaction with body tissue and help them stay in place. The FDA’s recall of Allergan’s breast implants comes after 38 countries already recalled the company’s products. The initial concerns over the safety of Allergan textured breast implants began in March of 2017. The FDA resisted an initial recall because the administration stated that it needed to further study the issue. By the time of its July 2019 recall, the FDA confirmed that the Allergan BIOCELL® Textured Implants had a significant correlation with BIA-ALCL.

The recalled implants include:

  • Natrelle Saline-Filled breast implants
  • Natrelle Silicone-Filled breast implants
  • Natrelle Inspira Silicone-Filled breast implants
  • Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants

The recall also includes tissue expanders used by patients before breast augmentation or reconstruction, including:


  • Natrelle 133 Plus Tissue Expander
  • Natrelle 133 Tissue Expander with Suture Tabs

What is BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) and The Symptoms?

BIA-ALCL is not a type of breast cancer. It is a rare type of lymphoma, which is a cancer of the immune system. As a rare cancer, the correlation between The BIA-ALCL cancer and recipients of the Allergan implants have a high correlation.  It develops in tissue or capsule around the implant. Removing the implant and the scar tissue around it can cure the patient. However, if the disease is not caught early, the cancer can spread and be fatal.

Women who have implants affected by the recall do not need to have them removed, but should have regular follow-ups with their doctor and report any symptoms of BIA-ALCL, such as excessive fluid buildup around the breast implant causing pain, swelling or lumps in the breast or armpit. Symptoms usually occur between three and 14 years after implant placement.



  • Breast pain
  • Swelling or lumps
  • Asymmetry of the breast
  • Fever
  • Loss of appetite
  • Tiredness
  • Night sweats
  • Weight loss
  • Painless swelling in the armpit, neck or groin
  • Enlarged lymph nodes

What does the FDA suggest to those with Textured Implants?

Currently, the FDA does not recommend that those free of BIA-ALCL symptom have their implants removed. Instead, the administration has urged those with textured implants to monitor and report any changes to their healthcare provider. Cancer from textured implants can take years to develop, so the FDA suggests close and regular monitoring for symptoms.

Filing an Allergan BIOCELL® Textured Breast Implant BIA-ALCL Lawsuit May Help

Individuals diagnosed with BIA-ALCL from Allergan BIOCELL® Textured Breast Implants may be able to seek compensation. It is important to contact The Olinde Firm today at 1-800-587-1889 to receive your Free Consultation.


  • This field is for validation purposes and should be left unchanged.

If You Have Been Diagnosed With BIA-ALCL From Allergan BIOCELL® Textured Breast Implants, You May Be Eligible For Compensation. Contact Us For A FREE CONSULTATION.

New Orleans

Of Counsel at Huber, Thomas & Marcelle
1100 Poydras Street, Suite 2200
New Orleans, LA 70163

Phone: (504) 587-1440
Toll Free:1-800-587-1889

North Shore

Mailing Address
P.O. Box 55
Mandeville, LA 70470

Phone: (504) 587-1440
Toll Free: 1-800-587-1889

New Orleans East

New Orleans East Office
8816 Chef Menteur Highway
Suite B
New Orleans, LA 70127

Phone: (504) 587-1440
Toll Free: 1-800-587-1889

Free Case Evaluation

Copyright © 2020 The Olinde Firm - New Orleans Attorneys. All rights reserved. Disclaimer The information contained in this website may be considered advertising under the Rules of the Supreme Judicial Court of Louisiana and is for general information purposes only. Nothing contained within this or associated pages, documents, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and communications exchanged in connection with this website are not intended to create or constitute an attorney-client relationship. Although all communications are considered confidential, we do not accept representation of clients until such time as we enter into a written agreement for such representation.